Yerly S - Search Results

1

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen M, Schmit JC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA; SPREAD Programme. Wensing AM, et al. Among authors: yerly s. J Infect Dis. 2005 Sep 15;192(6):958-66. doi: 10.1086/432916. Epub 2005 Aug 15. J Infect Dis. 2005. PMID: 16107947

2

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.

Yerly S, Chamot E, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1992 Aug;166(2):269-76. doi: 10.1093/infdis/166.2.269. J Infect Dis. 1992. PMID: 1353103

3

Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective study.

Yerly S, Chamot E, Déglon JJ, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1991 Nov;164(5):965-8. doi: 10.1093/infdis/164.5.965. J Infect Dis. 1991. PMID: 1940476

4

Response of HIV RNA to didanosine as a predictive marker of survival.

Yerly S, Kaiser L, Mermillod B, Baumberger C, Hirschel B, Perrin L. Yerly S, et al. AIDS. 1995 Feb;9(2):159-63. AIDS. 1995. PMID: 7718186

5

Foscarnet decreases human immunodeficiency virus RNA.

Kaiser L, Perrin L, Hirschel B, Furrer H, Von Overbeck J, Olmari M, Yerly S. Kaiser L, et al. Among authors: yerly s. J Infect Dis. 1995 Jul;172(1):225-7. doi: 10.1093/infdis/172.1.225. J Infect Dis. 1995. PMID: 7797916 Clinical Trial.

6

Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.

Yerly S, Kaiser L, Baumberger C, Hirschel B, Perrin LH. Yerly S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):358-64. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882100

7

V3 sequences in primary HIV-1 infection.

Antonioli IM, Baumberger C, Yerly S, Perrin L. Antonioli IM, et al. Among authors: yerly s. AIDS. 1995 Jan;9(1):11-7. doi: 10.1097/00002030-199501000-00002. AIDS. 1995. PMID: 7893436

8

High levels of circulating RNA in patients with symptomatic HIV-1 infection.

Baumberger C, Kinloch-de-Loës S, Yerly S, Hirschel B, Perrin L. Baumberger C, et al. Among authors: yerly s. AIDS. 1993 Nov;7 Suppl 2:S59-64. doi: 10.1097/00002030-199311002-00013. AIDS. 1993. PMID: 7909226

9

Mother to child transmission of zidovudine-resistant HIV-1.

Siegrist CA, Yerly S, Kaiser L, Wyler CA, Perrin L. Siegrist CA, et al. Among authors: yerly s. Lancet. 1994 Dec 24-31;344(8939-8940):1771-2. Lancet. 1994. PMID: 7997023 No abstract available.

10

Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donor.

de Saussure P, Yerly S, Tullen E, Perrin LH. de Saussure P, et al. Among authors: yerly s. Transfusion. 1993 Feb;33(2):164-7. doi: 10.1046/j.1537-2995.1993.33293158051.x. Transfusion. 1993. PMID: 8430457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page